Novan Announces Presentation of Anti-Viral Data at International Papillomavirus Conference

Novan, Inc. today announced that preclinical data demonstrating the anti-viral effects of the Company’s nitric oxide-releasing drug candidates will be presented at the 31st International Papillomavirus Conference in Cape Town, South Africa. Thomas Broker, Ph.D., and Louise Chow, Ph.D., both of the University of Alabama at Birmingham, or UAB, are scheduled to present “Antiviral Efficacy of Nitric Oxide-Releasing Drug Candidates in Suppressing Productive Infection by HPV-18 in the Organotypic Epithelial Raft Culture Model System” on Thursday, Mar. 2. Drs.

Surveillance and Research Group at YSPH Refunded with $14 Million Grant

The Connecticut Emerging Infections Program , a collaboration between Yale School of Public Health and CT Department of Public Health, has been awarded a five-year, $14 million grant from the Centers of Disease Control and Prevention to continue its ongoing research and surveillance of infectious diseases in Connecticut. The Yale EIP tracks a wide range of infectious diseases that impact state residents, including cases of food-borne disease caused by common bacteria and parasites, C. difficile and other infections in health care and community settings, influenza-related hospitalizations, pre-cancerous cervical lesions due to human papillomavirus infections and Lyme and other tick-borne diseases.

N.H. House committee says Hepatitis B vaccine shouldn’t be required to attend school NEW

Hepatitis B and other diseases deemed “non-communicable in a child care or school setting” would be removed from the list of vaccines required by the state under a bill that got a surprise boost Wednesday from a House committee. The bill, passed by the House Health, Human Services and Elderly Affairs Committee on a 9-8 vote, says the vaccines cannot be required for enrollment in public school or child care facilities.

Doctors seek to quell cervical cancer fear

The biennial pap smear will become a thing of the past from May 1, replaced by a test sexually-active women will need just once every five years, from age 25 instead of 18. That’s sparked fears by some that the less frequent testing will put lives at risk, but doctors stress that is not the case. More than 50,000 people have signed a change.org petition this week urging the federal government to scrap the changes, labelling it a dangerous cost-cutting exercise.

HPV vaccine now funded for boys

… experience. This vaccine has an excellent safety profile which has been reviewed and supported by the World Health Organization. The most common concern that arises is syncopal attacks (i.e. fainting), an effect of having an injection, which can be …

Understanding the HPV Vaccine

Join our expert panel of physicians in discussing the Human Papillomavirus vaccine and the questions, misconceptions and myths that surround it. Listen to them discuss the dangers of HPV, the different strands, why the HPV vaccine is so important and how it helps.

Global HPV Testing Market 2016-2020; New Report Launched

According to Centers for Disease Control and Prevention , human papillomavirus refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals.

NCI-Designated Cancer Centers Endorse Updated HPV Vaccination Recommendations

Recognizing a critical need to improve national vaccination rates for the human papillomavirus , Yale Cancer Center has again united with each of the 69 National Cancer Institute -designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention . According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States.

How to Recognize HPV in Men

Genital human papillomavirus is probably the most common sexually transmitted infection , infecting almost all sexually active people at some point in their lives. Fortunately, there are more than 40 strains of HPV, and only a few of them lead to serious health risks.